|
|
 |
| |
IN THE NEWS- Black farmers look forward to USDA settlement
February 25, 2010 After juggling odd jobs to keep his Mississippi farm going for more than half a century, Harvey White figures help from the federal government is long overdue. - Pfizer Must Pay Woman $3.45 Million in Prempro Case
February 22, 2010 Feb. 22 (Bloomberg) -- Pfizer Inc.’s Wyeth unit must pay $3.45 million to a woman who argued the company’s Prempro menopause medicine helped cause her cancer, a Philadelphia jury ruled today - Government Announces $1.25 Billion Settlement in Black Farmer Litigation
February 18, 2010
- Biogen, Elan’s Drug Linked to 35 Brain-Disease Cases
February 16, 2010 Biogen Idec Inc.’s multiple sclerosis drug Tysabri has been linked to four new cases of a life-threatening brain illness, a spokeswoman said. - WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
February 15, 2010
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. - Lawsuit Claims Pfizer Deceived Doctors Into Prescribing Its Cholesterol Drug Lipitor
February 11, 2010
Jesse Polansky, a former director of outcomes management at Pfizer (PFE) from 2001 until 2003, has re-filed his whistleblower lawsuit regarding the cholesterol drug Lipitor, the best-selling prescription substance in the world and the backbone of the company. - FDA seeks to increase oversight of medical radiation
February 10, 2010 Federal regulators will require manufacturers of high-grade medical imaging machines to include safety controls that prevent patients from receiving excessive radiatin doses. - Popular antidepressant interferes with cancer drug
February 9, 2010 The popular antidepressant drug Paxil may interfere with breast cancer treatments, making patients more likely to relapse and die, researchers in Canada reported on Monday. - Studies Link Rare Ailment to Pain Pumps
January 27, 2010
When the first cases popped up in orthopedic journals, they read like medical mysteries. Surgeons around the country reported that several active young patients had suddenly developed chondrolysis, a relatively rare ailment in which joint cartilage dies, leaving bone to grind on bone. - Radiation safeguards said to lag amid advances in technology.
January 27, 2010
In New Jersey, 36 cancer patients at a veterans hospital in East Orange were overradiated — and 20 more received substandard treatment — by a medical team that lacked experience in using a machine that generated high-powered beams of radiation. The mistakes, which have not been publicly reported, continued for months because the hospital had no system in place to catch the errors. - Lawsuit claims Medtronic promoted device for off-label uses
January 26, 2010 Medtronic pays doctors to promote a medical device for off-label uses, and the InfuseBone Graft is "unreasonably dangerous" because its active ingredient can travel from the implant site to the esophagus or trachea, turning soft tissue into bone, a married couple claims in Los Angeles Superior Court.
- Drugs for depression, anxiety tied to preterm birth
January 21, 2010 Researchers found that among nearly 3,000 women who gave birth in Washington State, those who started taking antidepressants known as selective serotonin reuptake inhibitors (SSRIs) in the second or third trimester had a higher risk of preterm birth. - Group Urges Recall of Drug for Fibromyalgia
January 20, 2010 A consumer advocacy group is asking government regulators to recall a drug they approved last year for a little-understood pain ailment, saying the pill can lead to dangerously high blood pressure - Strollers Recalled in U.S. on Finger Amputation Risk
January 20, 2010
Jan. 20 (Bloomberg) -- Newell Rubbermaid Inc. is recalling 1.5 million strollers after reports of children’s fingertips getting caught in the products’ hinges, resulting in cuts and amputations, the U.S. Consumer Product Safety Commission said. - HRT raises risk of rare type of breast cancer
January 14, 2010
WASHINGTON — Hormone replacement therapy can raise the risk of an uncommon type of breast cancer fourfold after just three years, U.S. researchers reported on Monday.
They found women who took combined estrogen/progestin hormone-replacement therapy for three years or more had four times the usual risk of lobular breast cancer.
Their study, published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, is one of dozens trying to paint a clearer picture of what dangers might come from taking HRT to treat menopause symptoms. - Pfizer Must Face Menopause-Drug Award, Court Finds (Update2)
December 31, 2009 A Pfizer Inc. unit must face a $1.5 million damage award over one of its menopause drugs, a Pennsylvania appeals court ruled. - Pfizer Jury Said to Set Prempro Punitive Damages at $8 Million
December 23, 2009 Jurors said in 2007 that a Pfizer Inc. unit should pay more than $8 million in punitive damages to a woman who blamed the company’s menopause drugs for her breast cancer, according to people familiar with the sealed figure. - Bone Drug/Cancer News Highlights Women's Risky Therapy Choices
December 15, 2009 - Menopause: Marketing Fear
December 15, 2009 - Menopause, as Brought to You by
Big Pharma
December 13, 2009 MILLIONS of American women in the 1990s were told they could help their bodies ward off major illness by taking menopausal hormone drugs. Some medical associations said so. Many gynecologists and physicians said so. Respected medical journals said so, too. - CT Brain Perfusion Scans Safety Investigation
December 7, 2009 The FDA has identified at least 50 additional patients who were exposed to excess radiation of up to eight times the expected level during CT perfusion scans. - Risk of Neural Tube Birth Defects following prenatal exposure to Valproate
December 3, 2009 The FDA is reminding health care professionals about the increased risk of neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular malformations, in babies exposed to valproate sodiumand related products (valproic acid and divalproex sodium) during pregnancy. - FDA Drug Safety Newsletter-Post Market Reviews
December 3, 2009 - Wal-Mart to Pay $40M to Workers in Mass.
December 2, 2009 Wal-Mart has agreed to pay $40 million to 87,500 employees who claimed they refused overtime. . . - The FDA May Tighten Rules on Omniscan, a GE MRI Drug
December 2, 2009 - BIG PHARMA'S CRIME SPREE
December 2, 2009 Rather than having a deterrent effect, the number of Big Pharma high profile criminal settlements is increasing and the settlements are getting bigger. - Batch of H1N1 vaccine pulled after bad reactions
November 20, 2009 More than 100,000 doses of the H1N1 vaccine are being withdrawn across the country, after Manitoba health officials announced Thursday they'd noticed a higher-than-usual number of allergic reactions from one batch - New Pain Device Warnings
November 17, 2009 Federal regulators are demanding changes to labels on devices that deliver pain killers directly to joints after surgery, in response to numerous reports of irreversible cartilage damage.
- Report shows Pfizer's hand in Neurontin studies
November 11, 2009 A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market, U.S. researchers said on Wednesday, offering a look at how drugmakers influence scientific research. -
Certain antibiotics may up birth defect risk
November 3, 2009 Some of the antibiotics used to treat urinary tract infections during pregnancy may increase the risk of several birth defects if a woman uses them early in pregnancy, a new study in the Archives of Pediatrics & Adolescent Medicine shows. - Wyeth to Face New Trial on Punitive Damages in Hormone Replacement Case
November 2, 2009 - FDA Questions Role of Payments in Zimmer Study
November 2, 2009 Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial data. - Study Finds Stroke Risk from Anemia Drug Aranesp
October 30, 2009 A new study raises fresh safety concerns about widely used anemia medicines. - Amylin, Lilly’s Byetta Gets Stronger Safety Warning
October 30, 2009 Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said safety warnings were strengthened for their diabetes drug Byetta relating to the risks of pancreatitis and the medicine’s use by patients with severe kidney disease. - Pfizer Unit’s Prempro Punitive Damages Verdict Remains Secret
Pfizer Unit’s Prempro Punitive Damages Verdict Remains Secret - Judge seals damage award against Wyeth
October 27, 2009 A Philadelphia jury yesterday awarded punitive damages to an Illinois woman who said Wyeth's Prempro hormone replacement therapy caused her breast cancer, but the world will have to wait at least another month before anyone knows how much. - Pa. jury returns verdict in Prempro-cancer case
October 26, 2009 A Philadelphia jury returned a sealed punitive-damages verdict Monday against drugmaker Wyeth Pharmaceuticals after finding a link between a woman's breast cancer and the hormone-replacement drug she took. - Pfizer Unit Must Pay Prempro Damages, Jury Concludes
October 23, 2009 A Pfizer Inc. unit concealed the breast-cancer risks of its hormone-replacement therapy drug Prempro and is liable for $3.7 million in damages to an Illinois woman, a Philadelphia jury ruled in the second phase of a trial. - Glaxo must pay $2.5M in Paxil Case
October 13, 2009 GlaxoSmithKline P.L.C. must pay $2.5 million to settle a claim that its antidepressant Paxil caused severe heart defects in a 3-year-old Bensalem boy, a Philadelphia Common Pleas Court jury found today.
- Antidepressants May Be Linked to Birth Problems
Fall, 2009 Taking a popular type of antidepressant during pregnancy may increase the risk for preterm birth, the need for treatment in a neonatal intensive care unit and lower overall health for the baby, according to a new study.
- Concerns over oral contraceptives spur investigations, FDA review.
September 26, 2009 The oral contraceptives Yaz and Yasmin put women at higher risk for blood clots, strokes and other health problems than some other birth control pills do.
- FDA says updated Januvia label to contain information about acute pancreatitis risk. (HTML)
September 26, 2009 - FDA continues to receive reports of progressive multifocal leukoencephalopathy in patients receiving Tysabri
September 17, 2009 - Immunosuppressant Drugs: Required Labeling Changes - stronger warnings about the risk of BK virus-associated nephropathy (HTM )
July 14, 2009 - Pfizer Can't Exclude Witnesses in Neurontin Suits (COM/APPS/NEWS?PID=EMAIL_EN&SID=AURHVTRS4NSY)
May 8, 2009 - Antidepressant Suicide Cases Revived by Supreme Court (COM/APPS/NEWS?PID=NEWSARCHIVE&SID=AKLQDAGAWRE0)
March 9, 2009 - Wyeth, Drugmakers Lose as Top Court Allows Suits (COM/APPS/NEWS?PID=20601087&SID=AJHVUGV0AW4U&REFER=HOME)
March 4, 2009 "The decision means that product-liability cases that had been delayed while judges waited for the Supreme Court decision can now go forward," said Tobi Millrood, who represents women suing over Wyeth’s Premarin and Prempro menopause drugs.
“The decision makes clear that victims injured by these products are entitled to their day in court.”
- Raptiva "Dear Healthcare Professional" Letter (PDF)
- GENENTECH PROVIDES BLACK BOX WARNING FOR PSORIASIS DRUG RAPTIVA (HTML)
October 17, 2008
Updated Raptiva warnings to include risk of of life-threatening infections including bacterial sepsis, viral meningitis, invasive fungal disease and progressive multifocal leukoencephalopathy (PML). - "Get Out of Jail Free: How the Bush Administration Helps Corporations Escape Accountability" (PDF)
October 15, 2008
Washington—In a stealth effort coordinated at the highest levels of the Bush administration, multiple federal agencies were repeatedly ordered to usurp state law and undermine consumer protections, according to documents obtained through repeated FOIA requests by the American Association for Justice (AAJ). The documents released today detail how helping corporations escape accountability for dangerous products has been the administration’s top priority.
- Levine v Wyeth - Briefs Submitted to the U.S. Supreme Court
Several interested parties have filed "friend of the court" briefs on the issue of preemption currently before the U.S. Supreme Court in Levine v. Wyeth. - MedWatch - Fluoroquinolones: Boxed Warning to be added for risk of tendon rupture and tendinitis.
July 8, 2008 - FDA urging black box warning for epilepsy drugs
July 7, 2008 - Appellate Ruling Favors Drug Firms in Lawsuits
April 9, 2008 - Pfizer, GSK Win Ruling on Lawsuit Limits (COM/APPS/NEWS?PID=20601127&SID=AOZCBAZ2LB0W&REFER=LAW)
April 9, 2008 - FDA Warns of Association between Singulair and Suicide (HTM)
March 27, 2008 - Lawmakers Catch Glaxo Hiding Suicide Risks
February 13, 2008 - FDA Warns of Heparin Contamination (HTM)
February 11, 2008 - Senator Grassley Demands GSK Release Paxil Suicide Reports (HTM)
February 8, 2008 - FDA Issues Alert - Chantix May Cause Suicide (HTML)
February 4, 2008 - FDA Warns of Suicide Caused by Epileptic Drugs Like Neurontin (HTM)
January 31, 2008 - A Pivotal Medical-Device Case
January 3, 2008 - Preemption - Bush Administration Backs Medtronic in Supreme Court
January 1, 2008 According to Attorney Derek Braslow, of the Pennsylvania firm of Pogust & Braslow, "the goal of the Bush Administration's position is to achieve tort reform without obtaining consent from Congress." "The reality of preemption," he says, "allows companies to market unsafe products and avoid being sued when they deceive consumers about safety and effectiveness." - So Far, Victories Are Few as Breast Cancer
Patients Sue Wyeth Over Hormone Therapy
December 17, 2007 Millrood said Wyeth suggested that progestin be added to buffer the endometrium. “Of course, Wyeth was now marketing a known carcinogen (estrogen) to be taken with another promoter of breast tissue growth, progestin, without ever conducting a single study on the effects of breast tissue,” Millrood said. “Wyeth has admitted repeatedly that it never performed any long-term study — on humans or animals — to evaluate the risk of breast cancer in women taking combination estrogen and progestin.” - FDA's Advisor's Conclude "FDA's Flaws Put Lives at Risk"
December 3, 2007 - FDA Issues Early Communication for Chantix
November 21, 2007 The U.S. Food and Drug Administration (FDA), has issued an alert to physicians concerning the anti-smoking medication Chantix and the increased risk of depression, severe mood swings, suicidal ideation (thoughts), and suicidality. Click here to access the FDA's Release. - Pfizer's anti-smoking drug linked to depression -- Chantix
November 21, 2007 - Merck Agrees to Pay $4.85 Billion for Vioxx Claims
November 9, 2007 - Promoting Openness, Full Disclosure, and Accountability
November 9, 2007 - The U.S. Psycho-Pharmaceutical-Industrial Complex As mental illness has become profitable, we are seeing more of it
November 9, 2007 - Report Backs Up Warnings About Drug Avandia
June 27, 2007 - FDA grants priority to test antipsychotic drug for use by teens
June 6, 2007 - 15-Year Follow-Up Schizophrenia Study: No Drugs = Better Chance at Recovery
May 24, 2007 - Open-Source Drug Safety?
May 22, 2007 - WORLD PREMIERE OF "WE'LL TAKE CARE OF YOU" A Documentary Film by Lattanzio Firmian and Alberto Baudo
May 18, 2007 - FDA Issues New Warnings on Antidepressants
May 4, 2007 - The debate over drugs, teen and depression
May 1, 2007 - Patients Diagnosed Schizophrenic and Bipolar To Boost Seroquel Sales
April 11, 2007 - Parties Debate Weight Of FDA Preemption Rule In Zoloft Federal Case
April 3, 2007 - Suicide Warning For Antidepressants Should Be Raised To Include Young Adults, FDA Panel Says
April 3, 2007 - U.S. Drug Safety Laws Must Be Tougher, Families Say (Update1)
March 8, 2007 - Ireland Calls For Halt To Glaxo's Seroxat For Any New Pts
March 7, 2007 - FDA Issues Stronger Warnings for ADHD Stimulants; Warnings Don’t Go Far Enough
November 1, 2006 - Risky Rx: Drug maker's secret strategies ‘Disturbing’ glimpse into how marketing dupes doctors — and patients
August 15, 2006 - FDA red-faced over claims it is suppressing evidence
August 14, 2006 - BMJ Taming Who?
August 14, 2006 - OIG Report: FDA Fails to Monitor Adverse Safety Reports_BMJ--FDA Duplicity Exposed
August 14, 2006 - JAMA says it was misled by researchers
July 12, 2006 - Litigation Inoculation: New FDA policy aims to preempt suits over labels. A U.S. judge here said it was right.
July 9, 2006 - Deadly Newborn Lung Ailment Linked to Late-Pregnancy Depression Drugs
February 8, 2006 - Antidepressants and the risk of birth defects
January 26, 2006 - Antidepressant-suicide link debated
August 29, 2005 - Antidepressant Protest in front of White House
August 29, 2005 - Top-selling drug linked to increased suicide risk
August 22, 2005 - Europe's Medicine Agency Tightens Noose on Antidepressant Prescriptions for Kids
August 21, 2005 - Parents Cautioned About Multiple Psychiatric Medications for Children
August 9, 2005 - August 24 DC Protest Against the FDA- What's Everybody Mad About?
July 24, 2005 - Two Court Rulings Reject Pfizer-FDA Preemption Claim in Zoloft "failure to warn" cases
July 21, 2005 - Antidepressant efficacy may be overblown-experts
July 15, 2005 - 2000 study by Merck showed Vioxx risk
July 3, 2005 - FDA to Boost ADHD Drug Warnings
July 1, 2005 - FDA Moves Toward Harder Line on Suicide Risks
July 1, 2005 - FDA Advisory Suicide Risk for Adults on Antidepressants
July 1, 2005 - FDA: Suicidality in Adults Being Treated with Antidepressant Medications
June 30, 2005 - FDA to Warn on J&J's Concerta Drug
June 29, 2005 - FDA: Concerned With Psychiatric Risks With ADHD Drugs
June 28, 2005 - Hard to swallow Maine shouldn't let drug makers keep safety secrets
June 11, 2005 - Two to two & one/half times greater risk of suicide on antidepressants over placebo (PDF)
June 2005 - Regulator slaps Pfizer on Zoloft ads
May 6, 2005 - Warning on Prozac for children
April 26, 2005 - FDA requests anticonvulsants be reexamined
April 20, 2005 - FDA Antidepressant Medication Guide (PDF)
April 11, 2005 - Drug company rebuked
April 8, 2005 - Antidepressants carry risks
March 4, 2005 - FDA Tones Down Warning on Use Of Antidepressants In Children
March 4, 2005 - Are the SSRIs and Atypical Antidepressants Safe
and Effective for Children and Adolescents?
March 2, 2005 - Warning Didn't Slow Approval of MS Drug
March 2, 2005 - F.D.A. Official Admits 'Lapses' on Vioxx
March 2, 2005 - 10 Voters on Panel Backing Pain Pills Had Industry Ties
February 25, 2005 - NIH Clears Most Researchers In Conflict-of-Interest Probe
February 23, 2005 - Study ties antidepressants to suicide
February 21, 2005 - Drugs Raise Risk of Suicide
February 18, 2005 - FDA Maverick Whips Merck, Pfizer
February 17, 2005 - Whistleblower to Present Pain Drug Data
February 16, 2005 - FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers
February 16, 2005 - FDA Zoloft data
February 7, 2005 - Did Zoloft make him do it?
February 7, 2005 - Papers indicate firm knew possible Prozac suicide risk
January 4, 2005 - FDA Allows Scientist to Publish Data on Vioxx
January 4, 2005 - Choosing their words carefully
December 23, 2004 - Labeling Change Request Letter for Antidepressant Medications
October 28, 2004 - FDA Proposed Medication Guide: About Using Antidepressants in Children or Teenagers
- Suicidality in Children and Adolescents Being
Treated With Antidepressant Medications
October 15, 2004 - FDA Launches a Multi-Pronged Strategy to Strengthen Safeguards for Children Treated With Antidepressant Medications
October 15, 2004 - Congress Hammers FDA Over Handling of SSRIs
October 15, 2004 - FDA of Failing Act on Information About Link Between Antidepressants,
Suicide Risk in Children, Say Lawmakers
September 27, 2004 - US Reviewer Says Pressured in Antidepressant Probe
September 23, 2004 - FDA calls for warning on antidepressants
Drugs linked to increased suicide risk in children
September 15, 2004 - FDA, Psychpharmacologic Drugs Avisory Comm. & Pediatric Advisory Comm. Meeting (PDF)
September 14, 2004 - FDA, Psychpharmacologic Drugs Avisory Comm. & Pediatric Advisory Comm. Meeting (PDF)
September 13, 2004 - Researcher warns against antidepressants for kids
September 13, 2004 - Drugmaker admitted fraud, but sales flourish
August 16, 2004 - FDA Revisits Issue Of Antidepressants for Youths
New Analysis May Pressure Agency to Set Limit on Use Because of Suicide Risk
August 5, 2004 - Lilly Plans Broad Access To Results of Drug Trials
August 3, 2004 - Maker of drug admits hiding its risks
July 24, 2004 - A Medical Journal Quandary: How to Report on Drug Trials
June 21, 2004 - Stronger WARNING for SSRIs and other newer anti-depressants regarding the potential for behavioural and emotional changes, including risk of self-harm. (PDF)
June 2, 2004 - Regulators Want Antidepressants to List Warning
March 23, 2004 - Worsening Depression and Suicidality in Patients Being Treated with Antidepressant Medications
March 22, 2004 - Company 'held back' data on drug for children
Antidepressant had no effect, leak reveals
February 3, 2004 - FDA, Psychopharmacolgic Drugs Advisory Comm. Meeting (PDF)
February 2, 2004 - Antidepressant Makers Withhold Data on Children
January 29, 2004
|
 |
| |
|
|
|
 |
|